253 related articles for article (PubMed ID: 10902757)
1. A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French family.
Dodé C; Papo T; Fieschi C; Pêcheux C; Dion E; Picard F; Godeau P; Bienvenu J; Piette JC; Delpech M; Grateau G
Arthritis Rheum; 2000 Jul; 43(7):1535-42. PubMed ID: 10902757
[TBL] [Abstract][Full Text] [Related]
2. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus.
Ida H; Kawasaki E; Miyashita T; Tanaka F; Kamachi M; Izumi Y; Huang M; Tamai M; Origuchi T; Kawakami A; Migita K; Motomura M; Yoshimura T; Eguchi K
Rheumatology (Oxford); 2004 Oct; 43(10):1292-9. PubMed ID: 15280569
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes.
Aganna E; Hammond L; Hawkins PN; Aldea A; McKee SA; van Amstel HK; Mischung C; Kusuhara K; Saulsbury FT; Lachmann HJ; Bybee A; McDermott EM; La Regina M; Arostegui JI; Campistol JM; Worthington S; High KP; Molloy MG; Baker N; Bidwell JL; Castañer JL; Whiteford ML; Janssens-Korpola PL; Manna R; Powell RJ; Woo P; Solis P; Minden K; Frenkel J; Yagüe J; Mirakian RM; Hitman GA; McDermott MF
Arthritis Rheum; 2003 Sep; 48(9):2632-44. PubMed ID: 13130484
[TBL] [Abstract][Full Text] [Related]
4. An Israeli Arab patient with a de novo TNFRSF1A mutation causing tumor necrosis factor receptor-associated periodic syndrome.
Aganna E; Zeharia A; Hitman GA; Basel-Vanagaite L; Allotey RA; Booth DR; Hawkins PN; Thacker C; Syndercombe-Court D; McDermott MF
Arthritis Rheum; 2002 Jan; 46(1):245-9. PubMed ID: 11817598
[TBL] [Abstract][Full Text] [Related]
5. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
[TBL] [Abstract][Full Text] [Related]
6. A new mutation causing autosomal dominant periodic fever syndrome in a Danish family.
Weyhreter H; Schwartz M; Kristensen TD; Valerius NH; Paerregaard A
J Pediatr; 2003 Feb; 142(2):191-3. PubMed ID: 12584543
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Dutch family: evidence for a TNFRSF1A mutation with reduced penetrance.
Aganna E; Aksentijevich I; Hitman GA; Kastner DL; Hoepelman AI; Posma FD; Zweers EJ; McDermott MF
Eur J Hum Genet; 2001 Jan; 9(1):63-6. PubMed ID: 11175303
[TBL] [Abstract][Full Text] [Related]
9. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome.
Dodé C; André M; Bienvenu T; Hausfater P; Pêcheux C; Bienvenu J; Lecron JC; Reinert P; Cattan D; Piette JC; Szajnert MF; Delpech M; Grateau G;
Arthritis Rheum; 2002 Aug; 46(8):2181-8. PubMed ID: 12209523
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa.
Stojanov S; Lohse P; Lohse P; Hoffmann F; Renner ED; Zellerer S; Kéry A; Shin YS; Haas D; Hoffmann GF; Belohradsky BH
Arthritis Rheum; 2004 Jun; 50(6):1951-8. PubMed ID: 15188372
[TBL] [Abstract][Full Text] [Related]
11. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
Rebelo SL; Amel-Kashipaz MR; Radford PM; Bainbridge SE; Fiets R; Fang J; McDermott EM; Powell RJ; Todd I; Tighe PJ
Arthritis Rheum; 2009 Jan; 60(1):269-80. PubMed ID: 19116900
[TBL] [Abstract][Full Text] [Related]
12. Monocytic fasciitis: a newly recognized clinical feature of tumor necrosis factor receptor dysfunction.
Hull KM; Wong K; Wood GM; Chu WS; Kastner DL
Arthritis Rheum; 2002 Aug; 46(8):2189-94. PubMed ID: 12209524
[TBL] [Abstract][Full Text] [Related]
13. Autosomal dominant periodic fever with AA amyloidosis: tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Turkish family.
Dinc A; Erdem H; Rowczenio D; Simsek I; Pay S; Bahce M; Lachmann H
J Nephrol; 2005; 18(5):626-9. PubMed ID: 16299693
[TBL] [Abstract][Full Text] [Related]
14. Expression of tumor necrosis factor receptors on granulocytes in patients with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Hasegawa M; Nishii C; Ohashi A; Tomita M; Nakai S; Murakami K; Nabeshima K; Fujita Y; Ishii J; Hiki Y; Sugiyama S
Nephron Clin Pract; 2009; 113(3):c222-33. PubMed ID: 19690440
[TBL] [Abstract][Full Text] [Related]
15. Hereditary, familial, and idiopathic chronic pancreatitis are not associated with polymorphisms in the tumor necrosis factor alpha (TNF-alpha) promoter region or the TNF receptor 1 (TNFR1) gene.
Schneider A; Pogue-Geile K; Barmada MM; Myers-Fong E; Thompson BS; Whitcomb DC
Genet Med; 2003; 5(2):120-5. PubMed ID: 12644782
[TBL] [Abstract][Full Text] [Related]
16. Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder.
Grassi-Oliveira R; Brietzke E; Pezzi JC; Lopes RP; Teixeira AL; Bauer ME
Psychiatry Clin Neurosci; 2009 Apr; 63(2):202-8. PubMed ID: 19175760
[TBL] [Abstract][Full Text] [Related]
17. A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal-dominant recurrent fever.
Nevala H; Karenko L; Stjernberg S; Raatikainen M; Suomalainen H; Lagerstedt A; Rauta J; McDermott MF; Peterson P; Pettersson T; Ranki A
Arthritis Rheum; 2002 Apr; 46(4):1061-6. PubMed ID: 11953985
[TBL] [Abstract][Full Text] [Related]
18. Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus.
Fernandez-Real JM; Lainez B; Vendrell J; Rigla M; Castro A; Peñarroja G; Broch M; Pérez A; Richart C; Engel P; Ricart W
Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E952-9. PubMed ID: 11882518
[TBL] [Abstract][Full Text] [Related]
19. Cloning and expression of porcine recombinant soluble tumor necrosis factor receptor 1.
Maroushek Boury N; Bosworth BT; Stabel TJ; Kehrli ME; Taylor MJ
Am J Vet Res; 1998 Oct; 59(10):1317-22. PubMed ID: 9781468
[TBL] [Abstract][Full Text] [Related]
20. Analysis of human tumour necrosis factor receptor 1 dominant-negative mutants reveals a major region controlling cell surface expression.
Fielding CA; Siebert S; Rowe M; Brennan P
FEBS Lett; 2004 Jul; 570(1-3):138-42. PubMed ID: 15251454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
